Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVNT | Common Stock | Options Exercise | $84.2K | +2.4K | +44.99% | $35.07 | 7.73K | Jan 8, 2024 | Direct | |
transaction | AVNT | Common Stock | Disposed to Issuer | -$87.1K | -2.26K | -29.21% | $38.55 | 5.48K | Jan 8, 2024 | Direct | |
holding | AVNT | Common Stock | 28.1K | Jan 8, 2024 | Supplemental Plan | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVNT | Stock Appreciation Rights | Options Exercise | $0 | -2.4K | -100% | $0.00* | 0 | Jan 8, 2024 | Common Stock | 2.4K | $35.07 | Direct | F2 |
Id | Content |
---|---|
F1 | The information in this report is based on a plan statement as of January 8, 2024. |
F2 | SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $35.07 per share and no more than one-third of the grant can vest per year during the first three years. |